Literature DB >> 10473486

Handling uncertainty in economic evaluations of healthcare interventions.

A H Briggs1, A M Gray.   

Abstract

Mesh：

Year:  1999        PMID： 10473486      PMCID： PMC1116497          DOI： 10.1136/bmj.319.7210.635

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.

Authors:  A H Briggs; C Z Mooney; D E Wonderling
Journal:  Stat Med       Date:  1999-12-15       Impact factor: 2.373

2.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

Authors:  M A Chaudhary; S C Stearns
Journal:  Stat Med       Date:  1996-07-15       Impact factor: 2.373

3.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

4.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

Authors:  D Polsky; H A Glick; R Willke; K Schulman
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

Review 5.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

Authors:  A H Briggs; D E Wonderling; C Z Mooney
Journal:  Health Econ       Date:  1997 Jul-Aug       Impact factor: 3.046

6.  The analysis of censored treatment cost data in economic evaluation.

Authors:  P Fenn; A McGuire; V Phillips; M Backhouse; D Jones
Journal:  Med Care       Date:  1995-08       Impact factor: 2.983

7.  Implications for present and future applications of the implantable cardioverter-defibrillator resulting from the use of a simple model of cost efficacy.

Authors:  M H Anderson; A J Camm
Journal:  Br Heart J       Date:  1993-01

8.  Confidence intervals for cost/effectiveness ratios.

Authors:  P Wakker; M P Klaassen
Journal:  Health Econ       Date:  1995 Sep-Oct       Impact factor: 3.046

9.  Costs, effects and C/E-ratios alongside a clinical trial.

Authors:  B A van Hout; M J Al; G S Gordon; F F Rutten
Journal:  Health Econ       Date:  1994 Sep-Oct       Impact factor: 3.046

10.  In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.

Authors:  B J O'Brien; M F Drummond; R J Labelle; A Willan
Journal:  Med Care       Date:  1994-02       Impact factor: 2.983
View more
  45 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

Review 2.  Sample size determination for cost-effectiveness trials.

Authors:  Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

Review 3.  Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.

Authors:  Eleanor M Heather; Katherine Payne; Mark Harrison; Deborah P M Symmons
Journal:  Pharmacoeconomics       Date:  2014-02       Impact factor: 4.981

Review 4.  Economic evaluations: a new avenue of outcome assessment in spinal disorders.

Authors:  Nicole van der Roer; Norbert Boos; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

5.  Estimating 'costs' for cost-effectiveness analysis.

Authors:  Alec Miners
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.

Authors:  Rebecca Palmer; Munyaradzi Dimairo; Nicholas Latimer; Elizabeth Cross; Marian Brady; Pam Enderby; Audrey Bowen; Steven Julious; Madeleine Harrison; Abualbishr Alshreef; Ellen Bradley; Arjun Bhadhuri; Tim Chater; Helen Hughes; Helen Witts; Esther Herbert; Cindy Cooper
Journal:  Health Technol Assess       Date:  2020-04       Impact factor: 4.014

7.  Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Authors:  A T Newall; M Jit; R Hutubessy
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

8.  The cost-effectiveness of the RSI QuickScan intervention programme for computer workers: Results of an economic evaluation alongside a randomised controlled trial.

Authors:  Erwin M Speklé; Judith Heinrich; Marco J M Hoozemans; Birgitte M Blatter; Allard J van der Beek; Jaap H van Dieën; Maurits W van Tulder
Journal:  BMC Musculoskelet Disord       Date:  2010-11-11       Impact factor: 2.362

9.  Internet-Based Cognitive Behavioral Therapy for Insomnia: A Health Economic Evaluation.

Authors:  Hanne Thiart; David Daniel Ebert; Dirk Lehr; Stephanie Nobis; Claudia Buntrock; Matthias Berking; Filip Smit; Heleen Riper
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

10.  Combined bias suppression in single-arm therapy studies.

Authors:  Harald J Hamre; Anja Glockmann; Gunver S Kienle; Helmut Kiene
Journal:  J Eval Clin Pract       Date:  2008-03-24       Impact factor: 2.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.